Molecular insights into the binding selectivity of a synthetic ligand DAAG to Fc fragment of IgG

Journal of Molecular Recognition

Volumn 27, Issue 5, 2014, Pages 250-259

  Wang, Rong Zhu ^a   Lin, Dong Qiang ^b   Tong, Hong Fei ^b   Yao, Shan Jing ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

affinity chromatography; immunoglobulin G; molecular docking; molecular dynamics simulation; molecular interactions; peptide ligand

Indexed keywords

IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; LIGAND; PROTEIN BINDING;

BINDING SITE; CHEMICAL PHENOMENA; CHEMICAL STRUCTURE; CHEMISTRY; METABOLISM; THERMODYNAMICS;

BINDING SITES; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; LIGANDS; MODELS, MOLECULAR; PROTEIN BINDING; THERMODYNAMICS;

EID: 84898727838     PISSN: 09523499     EISSN: 10991352     Source Type: Journal    
DOI: 10.1002/jmr.2356     Document Type: Article

References (34)

1. Branco RJ, Dias AM, Roque AC,. 2012. Understanding the molecular recognition between antibody fragments and protein A biomimetic ligand. J. Chromatogr. A 1244: 106-115.
2. Brooks BR, Bruccoleri RE, Olafson BD, States DJ, Swaminathan S, Karplus M,. 1983. CHARMM: a program for macromolecular energy, minimization, and dynamics calculations. J. Comput. Chem. 4 (2): 187-217.
3. Budkowska A, Riottot MM, Dubreuil P, Lazizi Y, Brechot C, Sobczak E, Petit MA, Pillot J,. 1986. Monoclonal antibody recognizing pre-S(2) epitope of hepatitis B virus: characterization of pre-S(2) epitope and anti-pre-S(2) antibody. J. Med. Virol. 20 (2): 111-125.
4. Chennamsetty N, Voynov V, Kayser V, Helk B, Trout BL,. 2010. Prediction of aggregation prone regions of therapeutic proteins. J. Phys. Chem. B 114 (19): 6614-6624.
5. Chhatre S, Titchener-Hooker NJ, Newcombe AR, Keshavarz-Moore E,. 2007. Purification of antibodies using the synthetic affinity ligand absorbent MAbsorbent A2P. Nat. Protoc. 2 (7): 1763-1769.
6. Darden T, York D, Pedersen L,. 1993. Particle mesh Ewald: an Ṅ log (N) method for Ewald sums in large systems. J. Chem. Phys. 98 (12): 10089-10092.
7. Deisenhofer J,. 1981. Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-Å resolution. Biochemistry 20 (9): 2361-2370.
8. DeLano WL, Ultsch MH, de Vos AM, Wells JA,. 2000. Convergent solutions to binding at a protein-protein interface. Science 287 (5456): 1279-1283.
9. Diller DJ, Merz KM,. 2001. High throughput docking for library design and library prioritization. Proteins 43 (2): 113-124.
10. Fassina G, Verdoliva A, Palombo G, Ruvo M, Cassani G,. 1998. Immunoglobulin specificity of TG19318: a novel synthetic ligand for antibody affinity purification. J. Mol. Recognit. 11 (1-6): 128-133.
11. Fischer E,. 1894. Einfluss der Configuration auf die Wirkung der Enzyme. Ber. Dt. Chem. Ges. 27: 2985-2993.
12. Ghosh R,. 2002. Protein separation using membrane chromatography: opportunities and challenges. J. Chromatogr. A 952 (1): 13-27.
13. Goldenberg MM,. 1999. Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer. Clin. Ther. 21 (2): 309-318.
14. Hansch C, Björkroth J, Leo A,. 1987. Hydrophobicity and central nervous system agents: on the principle of minimal hydrophobicity in drug design. J. Pharm. Sci. 76 (9): 663-687.
15. Hober S, Nord K, Linhult M,. 2007. Protein A chromatography for antibody purification. J. Chromatogr. B 848 (1): 40-47.
16. Humphrey W, Dalke A, Schulten K,. 1996. VMD: visual molecular dynamics. J. Mol. Graphics 14 (1): 33-38, 27-28.
17. Huse K, Bohme HJ, Scholz GH,. 2002. Purification of antibodies by affinity chromatography. J. Biochem. Biophys. Methods 51 (3): 217-231.
18. Johannsen I, Galleco MR, Michael R, Ambrosius D, Jacobi A,. 2006. Antibody binding affinity ligands. Patent no. WO 2006/066598.
19. Li W, Zhou R, Mu Y,. 2012. Salting effects on protein components in aqueous NaCl and urea solutions: toward understanding of urea-induced protein denaturation. J. Phys. Chem. B 116 (4): 1446-1451.
20. Lin DQ, Tong HF, Wang HY, Yao SJ,. 2012a. Molecular insight into the ligand-IgG interactions for 4-mercaptoethyl-pyridine based hydrophobic charge-induction chromatography. J. Phys. Chem. B 116 (4): 1393-1400.
21. Lin DQ, Tong HF, Wang HY, Shao S, Yao SJ,. 2012b. Molecular mechanism of hydrophobic charge-induction chromatography: interactions between the immobilized 4-mercaptoethyl-pyridine ligand and IgG. J. Chromatogr. A 1260: 143-153.
22. Lund LN, Gustavsson PE, Michael R, Lindgren J, Norskov-Lauritsen L, Lund M, Houen G, Staby A, St Hilaire PM,. 2012. Novel peptide ligand with high binding capacity for antibody purification. J. Chromatogr. A 1225: 158-167.
23. Mayo SL, Olafson BD, Goddard WA,. 1990. DREIDING: a generic force field for molecular simulations. J. Phys. Chem. 94 (26): 8897-8909.
24. Moreland LW, Baumgartner SW, Schiff MH, Tindall EA, Fleischmann RM, Weaver AL, Ettlinger RE, Cohen S, Koopman WJ, Mohler K, Widmer MB, Blosch CM,. 1997. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N. Engl. J. Med. 337 (3): 141-147.
25. Naik AD, Menegatti S, Gurgel PV, Carbonell RG,. 2011. Performance of hexamer peptide ligands for affinity purification of immunoglobulin G from commercial cell culture media. J. Chromatogr. A 1218 (13): 1691-1700.
26. Richter C, Schnabel A, Csernok E, De Groot K, Reinhold-Keller E, Gross WL,. 1995. Treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis with high-dose intravenous immunoglobulin. Clin. Exp. Immunol. 101 (1): 2-7.
27. Rocchia W, Sridharan S, Nicholls A, Alexov E, Chiabrera A, Honig B,. 2002. Rapid grid-based construction of the molecular surface and the use of induced surface charge to calculate reaction field energies: applications to the molecular systems and geometric objects. J. Comput. Chem. 23 (1): 128-137.
28. Ryckaert J-P, Ciccotti G, Berendsen HJ,. 1977. Numerical integration of the Cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J. Comput. Phys. 23 (3): 327-341.
29. Salvalaglio M, Zamolo L, Busini V, Moscatelli D, Cavallotti C,. 2009. Molecular modeling of protein A affinity chromatography. J. Chromatogr. A 1216 (50): 8678-8686.
30. Spassov VZ, Yan L,. 2008. A fast and accurate computational approach to protein ionization. Protein Sci. 17 (11): 1955-1970.
31. Teng SF, Sproule K, Husain A, Lowe CR,. 2000. Affinity chromatography on immobilized" biomimetic" ligands. Synthesis, immobilization and chromatographic assessment of an immunoglobulin G-binding ligand. J. Chromatogr. B 740 (1): 1-15.
32. Terman DS, Bertram JH,. 1985. Antitumor effects of immobilized protein A and staphylococcal products: linkage between toxicity and efficacy, and identification of potential tumoricidal reagents. Eur. J. Cancer Clin. Oncol. 21 (10): 1115-1122.
33. Wang HY, Lin DQ, Yao SJ, Yun JX, Yao KJ,. 2010. Molecular simulation of the interactions between 4-mercaptoethylpyridine ligand and IgG, Acta Chim. Sin. 68: 1597-1602.
34. Wu G, Robertson DH, Brooks CL, Vieth M,. 2003. Detailed analysis of grid-based molecular docking: a case study of CDOCKER-a CHARMm-based MD docking algorithm. J. Comput. Chem. 24 (13): 1549-1562.